Social Media Ideas for Bmy

Bristol Myers Squibb's Breakout Is Here: Portfolio Renewal Gaining Momentum

Bristol Myers Squibb vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?

Bristol Myers Squibb recovered to $7.1B in net income while Eli Lilly more than doubled profits to $20.6B, a stark contrast in momentum that reshapes the value-versus-growth debate...

Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?

Amgen boasts stronger revenue growth, while Bristol Myers Squibb generates nearly 60% more free cash flow at half the valuation.

3 Numbers That Explain Bristol Myers Squibb's Dirt Cheap Valuation

With this pharma company trading for less than 10 times earnings, the market remains very uncertain about its stock and looming patent cliff.

Should You Buy Bristol Myers Squibb Stock Right Now for the Yield Alone?

As management tackles key issues head-on, Bristol Myers Squibb stock offers a steady 4% yield, with further upside potential.

Can BMS be salvaged?

Can BMS be salvaged? Anonymous (not verified) Wed, 10/14/2026 - 10:12 field_thread_url https://cafepharma.com/boards/threads/can-bms-be-salvaged.698064/...

Can BMS be salvaged?

Can BMS be salvaged? Anonymous (not verified) Tue, 10/13/2026 - 07:11 field_thread_url https://cafepharma.com/boards/threads/can-bms-be-salvaged.698064/...

Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?

Bristol Myers Squibb trades at a steeper discount despite higher leverage, while Novo Nordisk commands a premium on exceptional profitability and GLP-1 dominance.

Bristol Myers Squibb and Johnson & Johnson Both Face Challenges Ahead: Which Healthcare Stock Looks More Resilient N...

Bristol Myers Squibb trades at a steep valuation discount, while Johnson & Johnson's stronger margins and lower debt offer stability. But patent cliffs and litigation risks com...

Bristol Myers Squibb vs. Pfizer: Consistency vs. Scale in Revenue

Pfizer's revenue swung sharply lower before stabilizing, while Bristol Myers Squibb kept climbing steadily—a divergence that matters for long-term investors.

BMS SUCKS!!!

BMS SUCKS!!! Anonymous (not verified) Fri, 09/25/2026 - 00:58 field_thread_url https://cafepharma.com/boards/threads/bms-sucks.660695/ b...

BMEZ Tender Offer Quick Notes

Syngene Expands Integrated Drug Development and Manufacturing Services with BMS

The collaboration between Syngene and Bristol Myers Squibb began in 1998, culminating in the establishment of the Biocon Bristol Myers Squibb Research and Development Center, Synge...

BioXcel files for Chapter 11, will sell assets to Teva

Divest BWI Now

Divest BWI Now Anonymous (not verified) Wed, 10/21/2026 - 13:15 field_thread_url https://cafepharma.com/boards/threads/divest-bwi-now.717817/...

Bumble: The Cigar Butt Delivered

<![CDATA[ Eli Lilly to Acquire Merida Biosciences for $2.8 Billion ]]>

Divest BWI Now

Divest BWI Now Anonymous (not verified) Tue, 09/29/2026 - 01:04 field_thread_url https://cafepharma.com/boards/threads/divest-bwi-now.717817/...